Visanne
Visanne contains Dienogest, a progestogen that effectively manages endometriosis symptoms by reducing estrogen production. It is specifically formulated to alleviate pain and discomfort associated with endometrial tissue growth outside the uterus. This medication helps in decreasing endometrial lesions and suppressing their recurrence. Taken orally, Visanne is designed for continuous daily use to provide ongoing relief and improve quality of life. It offers a targeted approach for women suffering from endometriosis by addressing hormonal imbalances. Regular use can significantly reduce menstrual pain and other related symptoms. Visanne is an important option for non-surgical management of endometriosis.Active substance:
DienogestPharmachologic effect:
Visanne contains dienogest, a progestin that reduces the production of estrogen in the ovaries and suppresses the growth of endometrial tissue, thereby alleviating symptoms of endometriosis.Indications:
- Treatment of endometriosis
Contraindications:
- Hypersensitivity to dienogest or any of the excipients
- Active venous thromboembolic disorder
- Arterial and cardiovascular disease
- Severe liver disease
- Known or suspected sex hormone-dependent malignancies
- Undiagnosed vaginal bleeding
Side effects:
In order of decreasing probability: Very common: Headache, breast discomfort, mood changes, Common: Nausea, acne, weight gain, decreased libido, Uncommon: Alopecia, anemia, depression, Rare: Thrombosis, liver function disturbances
Dosing and Administration:
The recommended dose is one tablet taken orally once daily, without any break, preferably at the same time each day. The tablet can be taken with or without food.
Storage:
Store at a temperature not exceeding 30°C (86°F).
Visanne
in Cyrillic : Визанна
SUBSTANCE
Dienogest
DOSAGE FORM
tablets
